Transform data into clinically-rich, research-grade evidence that shows how your treatment or therapy performs in real-world settings and what’s driving outcomes.
Our analytics technology delivers the evidence you need when and how you need it, and helps you accelerate your path to value.
We deliver exponential insights you can rely on to address your top priorities, deliver value, improve outcomes, and achieve results.
Acacia Pharma, a hospital pharmaceutical company, is leveraging a clinical registry to support a large observational study of post-operative nausea and vomiting (PONV). PONV has been cited as the most undesirable of all surgical complications, even worse than pain, in some patient surveys. It is a common complication of surgery and anesthesia that occurs in approximately 30% of surgical patients and up to 80% of high-risk patients.
The PROMPT (PONV Rescue Outcomes after aMisulPride Treatment) Study collects RWE on the presentation, evaluation, and rescue treatment of PONV. The registry-based study enables hospitals, surgeons, and anesthesia providers to better understand the drivers of perioperative complications and the impact of the management of those complications on patient throughput and workflow.
Sites that participate in the PROMPT Study use the PACE Registry to gain insight into deidentified, retrospective data collection from tens of thousands of patient records, leverage research-grade evidence suitable for publication, and access web-based reports on quality metrics, workflow, and throughput.